Abstract:Collagen, one of the main building blocks for various tissues, derives its mechanical properties directly from its structure of cross-linked tropocollagen molecules. The cross-links are considered to be a key component of collagen fibrils as they can change the fibrillar behavior in various ways. For instance, enzymatic cross-links (ECLs), one particular type of cross-links, are known for stabilizing the structure of the fibril and improving material properties, while cross-linking AGEs (Advanced-Glycation Endproducts) have been shown to accumulate and impair the mechanical properties of collageneous tissues. However, the reasons for whether and how a given type of cross-link improves or impairs the material properties remain unknown, and the exact relationship between the cross-link properties and density, and the fibrillar behavior is still not well understood. Here, we use coarse-grained steered molecular models to evaluate the effect of AGEs and ECLs cross-links content on the deformation and failure properties of collagen fibrils. Our simulations show that the collagen fibrils stiffen at high strain levels when the AGEs content exceeds a critical value. In addition, the strength of the fibril increases with AGEs accumulation. By analyzing the forces within the different types of cross-links (AGEs and ECLs) as well as their failure, we demonstrate that a change of deformation mechanism is at the origin of these observations. A high AGEs content reinforces force transfer through AGEs cross-links rather than through friction between sliding tropocollagen molecules, which leads to failure by breaking of bonds within the tropocollagen molecules. We show that this failure mechanism, which is associated with lower energy dissipation, results in more abrupt failure of the collagen fibril. Our results provide a direct and causal link between increased AGEs content, inhibited intra-fibrillar sliding, increased stiffness, and abrupt fibril fracture. Therefore, they explain the mechanical origin of bone brittleness as commonly observed in elderly and diabetic populations. Our findings contribute to a better understanding of the mechanisms underlying impaired tissue behavior due to elevated AGEs content and could enable targeted measures regarding the reduction of specific collagen cross-linking levels.

Advanced glycation end-products as mediators of the aberrant crosslinking of extracellular matrix in scarred liver tissue

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Scar-Degrading Endothelial Cells As a Treatment for Advanced Liver Fibrosis

Advanced glycation end products activate Smad signaling via TGF- -dependent and -independent mechanisms: implications for diabetic renal and vascular disease

Advanced Glycation End Product (Age)-Induced Hepatic Stellate Cell Activation Via Autophagy Contributes to Hepatitis C-related Fibrosis

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Biglycan promotes hepatic fibrosis through activating heat shock protein 47

The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review

Macrophage-derived cathepsin S remodels the extracellular matrix to promote liver fibrogenesis

Collagen crosslinking: effect on structure, mechanics and fibrosis progression

Biological Effects Induced by Specific Advanced Glycation End Products in the Reconstructed Skin Model of Aging

Nε-Carboxymethyl-Lysine Modification of Extracellular Matrix Proteins Augments Fibroblast Activation

Advanced glycation end products activated endothelial-to-mesenchymal transition in pancreatic islet endothelial cells and triggered islet fibrosis in diabetic mice

The influence of AGEs and enzymatic cross-links on the mechanical properties of collagen fibrils

Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression

Advanced Glycation End Products Alters Functions of End Othelial Progenitor Cells in Vitro

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

The regulatory role of the apelin/APJ axis in scarring: Identification of upstream and downstream mechanisms

Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment